德适-B(02526)今日盘中股价大幅拉升，涨幅达22.02%，表现十分抢眼。
消息面上，作为“医学影像大模型第一股”，德适专注AI医学影像领域的底层技术创新。公司自主研发的iMedImage®医学影像基座模型支持19种影像模态，可赋能超90%的临床影像场景。其核心产品AI AutoVision®已获国家药监局认定为三类创新医疗器械，有望成为全国首款获批上市的智能染色体核型辅助诊断软件，市场前景广阔。
此外，公司财务表现强劲，2025年前九个月营收同比激增469.8%至1.12亿元，毛利率高达75.9%。其产品已部署于全国400多家医疗机构，商业化落地能力得到初步验证。这些积极因素共同推动了股价的强势上涨，并使其市值突破了200亿港元大关。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.